A Novel Necroptosis-Related Signature Can Predict Prognosis and Chemotherapy Sensitivity in Multiple Myeloma.
Jun-Yao JiangFang-Yi YaoJing LiuXin-Lu WangBo HuangFang-Min ZhongXiao-Zhong WangPublished in: Technology in cancer research & treatment (2024)
A systematic analysis of NRGs can help identify potential necroptosis-related mechanisms and provide novel biomarkers for MM prognosis prediction, tumor microenvironment evaluation, and personalized treatment planning.